We are live on ! Find out more
DTIL icon

Precision BioSciences

134 hedge funds and large institutions have $233M invested in Precision BioSciences in 2021 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 30 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 30

2% more funds holding

Funds holding: 132134 (+2)

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

7% more call options, than puts

Call options by funds: $567K | Put options by funds: $530K

0.1% more ownership

Funds ownership: 1.63%1.73% (+0.1%)

31% less capital invested

Capital invested by funds: $337M → $233M (-$103M)

Holders
134
Holders Change
+2
Holders Change %
+1.52%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
48
Reduced
30
Closed
24
Calls
$567K
Puts
$530K
Net Calls
+$37K
Net Calls Change
-$1.13M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$32.5M +$1.94M +6,929 +5%
Capital World Investors
2
Capital World Investors
California
$31.6M
Vanguard Group
3
Vanguard Group
Pennsylvania
$24M +$1.42M +5,069 +5%
State Street
4
State Street
Massachusetts
$20.9M +$2.65M +9,502 +11%
ACH
5
ArrowMark Colorado Holdings
Colorado
$13.4M -$3.97M -14,223 -19%
OMC
6
OUP Management Company
Pennsylvania
$8.32M +$10.5M +37,464 New
Goldman Sachs
7
Goldman Sachs
New York
$7.14M +$2.84M +10,181 +46%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$6.8M +$290K +1,040 +4%
JP Morgan Chase
9
JP Morgan Chase
New York
$5.49M -$1.47M -5,275 -18%
Principal Financial Group
10
Principal Financial Group
Iowa
$5.04M +$1.79M +6,408 +39%
CS
11
Candriam SCA
Luxembourg
$4.68M
CA
12
CHI Advisors
New York
$4.49M -$373K -1,337 -6%
Northern Trust
13
Northern Trust
Illinois
$3.82M -$11.5K -41 -0.2%
Millennium Management
14
Millennium Management
New York
$3.65M +$1.5M +5,356 +48%
N
15
Nuveen
North Carolina
$3.52M +$135K +483 +3%
Acadian Asset Management
16
Acadian Asset Management
Massachusetts
$2.87M +$2.27M +8,134 +170%
MSAM
17
Moloney Securities Asset Management
Missouri
$2.72M -$74K -265 -2%
Charles Schwab
18
Charles Schwab
California
$2.59M +$151K +539 +5%
CAM
19
Cormorant Asset Management
Massachusetts
$2.56M
Adage Capital Partners
20
Adage Capital Partners
Massachusetts
$2.22M -$233K -833 -8%
Dimensional Fund Advisors
21
Dimensional Fund Advisors
Texas
$2.17M +$2.72M +9,754 New
SCM
22
Sio Capital Management
New York
$1.9M
TCM
23
Tekla Capital Management
Massachusetts
$1.66M +$1.5M +5,384 +256%
Bank of America
24
Bank of America
North Carolina
$1.51M +$1.4M +4,998 +274%
Morgan Stanley
25
Morgan Stanley
New York
$1.5M -$1.62M -5,801 -46%

DTIL Hedge Fund Activity: Q4 2021 in Review

134 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2021, worth a combined $233M — down 31% from $337M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DTIL positions and 24 closed out — a net gain of 2 holders — while 48 added to existing stakes and 30 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $2.84M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $3.97M.

  • 134 institutional investors held Precision BioSciences (DTIL) as of Q4 2021, up from 132 in Q3 2021.
  • Funds reported $233M of Precision BioSciences stock for Q4 2021, down 31% quarter-over-quarter.
  • 26 funds opened new Precision BioSciences positions in Q4 2021 and 24 closed out, a net change of +2 holders.
  • The largest Precision BioSciences buyer in Q4 2021 was Goldman Sachs, an estimated $2.84M added.
  • The largest Precision BioSciences seller in Q4 2021 was ArrowMark Colorado Holdings, an estimated $3.97M sold.

Based on aggregated 13F filings for Q4 2021.